Hubei Hongyuan Pharmaceutical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024

Hubei Hongyuan Pharmaceutical Technology Co Ltd is a China-based company mainly engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations. The Company is also engaged in the production of lithium hexafluorophosphate, one of the main materials for lithium battery electrolyte. The Company's main products are divided into organic chemical raw materials such as glyoxal in the ethylene glycol reaction chain, pharmaceutical intermediates such as glyoxylic acid, 2-methyl-5-nitroimidazole and other products, and raw materials such as metronidazole; Pharmaceutical intermediates guanine, diacetylguanine and other products in the reaction chain of methyl cyanoacetate and guanidine hydrochloride. The Company distributes its products in the domestic market and overseas markets.